HOHidayat Y. Ogunsola

Hidayat Y. Ogunsola

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hidayat Y. Ogunsola has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Global health perspectives on the comparative analysis of healthcare systems between Nigeria and Saudi Arabia

    by Olanrewaju Mustapha Saliu, Olalekan John Okesanya, Hassan Hakeem Kayode, Uthman Okikiola Adebayo, Don Eliseo Lucero-Prisno Iii, Hidayat Y. Ogunsola

  • Open Access

    A Systematic Review of Autoimmunity in 22q11.2 Deletion Syndrome

    by Hidayat Y. Ogunsola, Sana Malik, Hannah Rogers, Brad D. Pearce

    Background: The 22q11.2 Deletion Syndrome (22q11DS) is the most common chromosomal microdeletion disorder, characterised by a heterogeneous clinical spectrum including immunodeficiency, autoimmunity, and neuropsychiatric comorbidities. This systematic review critically appraises current evidence on autoimmunity in 22q11DS, fulfilling the need for an unbiased and comprehensive synthesis of the current literature. Methods: An extensive search was conducted through PubMed, Web of Science, EMBASE, CINAHL, and the Cochrane Library using Boolean combinations of relevant keywords. Qualitative studies, abstracts, conference proceedings and non-English studies were excluded. Results: A total of 82 peer-reviewed studies published since 1968 were identified. We identified a total of 40 distinct autoimmune conditions involving multiple organ systems. Haematological disorders were most frequently cited, followed by autoimmune thyroid diseases and systemic autoimmune diseases. Less common conditions included coeliac disease, psoriasis, vitiligo, alopecia areata, Raynaud’s phenomenon, and vasculitis, while 19 diseases appeared only as single-case reports. Neuropsychiatric manifestations were addressed in 24 studies. Conclusion: Our review confirms that autoimmunity is a complication of 22q11DS and highlights the need for epidemiological studies across organ-systems and inclusion of ethnically diverse populations. There was substantial variation in study designs, underscoring the need for more standardised approaches and larger sample sizes.


  • Open Access

    Systematic Literature Review on Public Health Impacts of Persistent Tic Disorders: Education and Employment

    by Helena J. Hutchins, Patricia Whalen, Jorge Verlenden, Hidayat Ogunsola, Brooke S. Staley, Rebecca T. Leeb, Wendy Wegman, Rebecca H. Bitsko

    Tourette syndrome and persistent tic disorders (TS/PTD) begin in childhood and can contribute to negative outcomes across the lifespan. A systematic review was conducted to summarize current evidence on education and employment outcomes among individuals with TS/PTD. The review summarized education and/or employment outcomes from 69 articles published between 2003 and March 5, 2025 that reported these outcomes for individuals with TS/PTD and a comparison group without TS/PTD. Of these studies, most included small samples of individuals with TS/PTD (less than 100), and those that reported on race or ethnicity were predominantly White. Only five studies on adult employment status and no studies on the transition to higher education were identified for inclusion. Children and adolescents with TS/PTD may experience poorer school-related quality of life, lower school competence, and more parent-reported school problems compared to those without TS/PTD. Although evidence was less robust, children and adolescents with TS/PTD may also be more likely to experience other negative school outcomes, including poor attitudes about school and low pass rates/frequent grade retention. Findings can be used by healthcare providers and school personnel to inform supports for students with TS/PTD. Adult employment status and transition to higher education for individuals with TS/PTD, and studies with larger, more heterogeneous samples, may be important directions for future research.


  • Prevalence and Types of Chronic Pain among Insured Individuals with Tic Disorders

    by Hidayat Y. Ogunsola, Michele K. Bohm, Kim Newsome, Joohi Jimenez‐Shahed, Rebecca H. Bitsko

    Background: Tic disorders are neurodevelopmental disorders characterized by motor and vocal tics. Individuals with tic disorders can experience pain due to tics. Objective: We compared the prevalence and types of chronic pain among insured individuals with and without tic disorders. Methods: We analyzed data for enrollees 6 to 64 years with and without tic disorders during 2016 to 2021 using the Merative MarketScan commercial and Medicaid databases via Treatment Pathways, an online analytic tool. We compared the prevalence of any chronic pain and nine specific types of chronic pain (eg, headache) during the year following tic disorder diagnosis or a random office visit for the comparison group (into 2023, as needed). We calculated prevalence ratios, 95% confidence intervals, and corresponding P ‐values using SAS software. Results: Among enrollees with commercial and Medicaid insurance, we identified 27,262 and 19,980 individuals with tic disorders, respectively. Overall, approximately 20% (21.4% commercial; 22.5% Medicaid) of individuals with tic disorders had any chronic pain. After stratifying by insurance type, age, and sex, prevalences of any pain and each pain type assessed were 1.1 to 7.5 times higher among those with tic disorders than those without tic disorders ( P < 0.0001). Headache, especially migraine, was notably more common among those with compared to those without tic disorders. Conclusions: Information about the prevalence and types of chronic pain among individuals with tic disorders across the lifespan may inform clinical guidelines and practice for appropriate pain assessment and management and help educate healthcare providers, individuals with tic disorders, and their caregivers.